| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/1997 | CA2247940A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 09/25/1997 | CA2247814A1 Pharmaceutically useful compounds |
| 09/25/1997 | CA2243509A1 Anti-idiotypic antibody vaccines |
| 09/25/1997 | CA2242342A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/24/1997 | EP0796866A1 Antithrombotic diamides |
| 09/24/1997 | EP0796864A2 Steroidal glycosides for treating hypercholesterolemia |
| 09/24/1997 | EP0796863A2 Steroidal glycosides for treating hypercholesterolemia |
| 09/24/1997 | EP0796862A2 Steriodal glycosides for treating hypercholesterolemia |
| 09/24/1997 | EP0796861A1 Silated derivatives of salicilic acid with desquamative properties |
| 09/24/1997 | EP0796858A1 Triazole antifungal agents |
| 09/24/1997 | EP0796857A1 4-thia-1-azabicyclo(3.2.0)heptane-3-imino-2-isopropylidene-7-oxo analogons of beta-lactams, processes for their preparation and the use thereof |
| 09/24/1997 | EP0796855A1 Inhibitors of bone resorption and vitronectin receptor antagonists |
| 09/24/1997 | EP0796854A1 Benzopyran derivative and use of said benzopyran derivative for treating heart disease |
| 09/24/1997 | EP0796849A1 Novel polycyclic aminopyridine compounds as acetylcholinesterase inhibitors, preparation process and use thereof |
| 09/24/1997 | EP0796848A1 Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists |
| 09/24/1997 | EP0796847A1 Pyridine derivative, anti-ulcer drug, and antibacterial drug |
| 09/24/1997 | EP0796846A1 2-Aryl substituted pyridines |
| 09/24/1997 | EP0796843A2 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives |
| 09/24/1997 | EP0796841A1 Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity |
| 09/24/1997 | EP0796623A2 Pharmaceutical preparation for the treatment of blood coagulation disorders |
| 09/24/1997 | EP0796621A2 Preventing and treating periodontal disease |
| 09/24/1997 | EP0796619A1 Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
| 09/24/1997 | EP0796618A1 Treatment and prophylaxis of pancreatitis |
| 09/24/1997 | EP0796617A1 Use of antiarhythmic compounds to reduce post-infarct mortality |
| 09/24/1997 | EP0796616A1 Propofol microdroplet formulations |
| 09/24/1997 | EP0796613A1 Process for reducing the photoblueing of a cosmetic composition containing titanium oxide pigments |
| 09/24/1997 | EP0796341A2 Identification of genes |
| 09/24/1997 | EP0796322A1 Production and use of human and plant methyltransferases |
| 09/24/1997 | EP0796266A1 Anti-tumour agents |
| 09/24/1997 | EP0796263A1 Cephem compounds and pharmaceutical use thereof |
| 09/24/1997 | EP0796262A1 7-alkylidene cephalosporanic acid derivatives and methods of using the same |
| 09/24/1997 | EP0796260A1 Rapamycin 42-oximes and hydroxylamines |
| 09/24/1997 | EP0796258A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
| 09/24/1997 | EP0796257A1 Malonic acid based matrix metalloproteinase inhibitors |
| 09/24/1997 | EP0796252A1 Bicyclic fibrinogen antagonists |
| 09/24/1997 | EP0796251A1 Uracil derivatives |
| 09/24/1997 | EP0796250A1 Pyridazinones as endothelin-receptor antagonists |
| 09/24/1997 | EP0796249A1 Compounds for inhibition of gastric acid secretion |
| 09/24/1997 | EP0796247A1 (-)-(3r)-3-methyl-4-(4-(4-(4-pyridyl)piperazin-1-yl]phenoxy butyric acid as cellular adhesion inhibitor |
| 09/24/1997 | EP0796245A1 PROCESS FOR THE PREPARATION OF AMIDINO PHENYL PYRROLIDINE $g(b)-ALANINE UREA ANALOGS |
| 09/24/1997 | EP0796243A1 Diaminocyclobutene-3,4-diones |
| 09/24/1997 | EP0796238A1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics |
| 09/24/1997 | EP0796112A1 Phosphocholine drug derivatives |
| 09/24/1997 | EP0796109A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 09/24/1997 | EP0796107A1 Sunscreen-wound healing composition |
| 09/24/1997 | EP0796103A1 Use of incense in the treatment of alzheimer's disease |
| 09/24/1997 | EP0796101A1 Compositions and methods for inhibiting fungal cell wall formation |
| 09/24/1997 | EP0796100A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 09/24/1997 | EP0796099A1 Use of xanthine oxidase inhibitors as anti-ischaemic agents |
| 09/24/1997 | EP0796098A1 Fibrinogen receptor antagonists |
| 09/24/1997 | EP0796097A1 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 09/24/1997 | EP0796096A1 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds |
| 09/24/1997 | EP0796095A1 Methods of inhibiting growth hormone effects |
| 09/24/1997 | EP0796094A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
| 09/24/1997 | EP0796093A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 09/24/1997 | EP0796092A1 3,3-(disubstituted)cyclohexan-1-one dimers and related compounds |
| 09/24/1997 | EP0796091A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds |
| 09/24/1997 | EP0796089A1 Diltiazem hydrochloride formulation |
| 09/24/1997 | EP0750609A4 Isoprenyl transferase inhibitors |
| 09/24/1997 | EP0696280B1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| 09/24/1997 | EP0673245B1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same |
| 09/24/1997 | EP0667864B1 Tricyclic compounds with pharmaceutical activity |
| 09/24/1997 | EP0653207B1 Aids virus infection inhibitor composition |
| 09/24/1997 | EP0617705B1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them |
| 09/24/1997 | EP0560928B1 Use of no for the treatment or prevention of bronchoconstriction |
| 09/24/1997 | EP0556296B1 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives |
| 09/24/1997 | EP0491708B1 Isolating aminoarginine and use to block nitric oxide formation in body |
| 09/24/1997 | EP0480925B1 Fluorocarbon emulsions having saturated phospholipid emulsifiers |
| 09/24/1997 | CN1160404A Pharmaceutical compositions contg. estra-1,3,5C10-triene derivs. |
| 09/24/1997 | CN1160402A Purine and guanine compounds as inhibitors of PNP |
| 09/24/1997 | CN1160401A Phenyl-oxo-alkyl-(4-piperidinyl) benzoate derivs. |
| 09/24/1997 | CN1160400A Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonists |
| 09/24/1997 | CN1160399A Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists |
| 09/24/1997 | CN1160398A Compositions and methods for treating mast-cell inflammatory condition |
| 09/24/1997 | CN1160397A Azole deriv. |
| 09/24/1997 | CN1160396A Carboxylic acid derivs., their preparation and their use |
| 09/24/1997 | CN1160356A Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 09/24/1997 | CN1160354A Aromatic composition and use in medicines, cosmetics, perfume or sanitary health articles espercially |
| 09/24/1997 | CN1160352A Diazepino-indoles as phosphodiesterase IV inhibitors |
| 09/24/1997 | CN1160351A Compounds and methods for treatment of cancer |
| 09/24/1997 | CN1160350A HIV protease inhibitor combination |
| 09/24/1997 | CN1160349A Codeine contg. formulations |
| 09/24/1997 | CN1160348A Sabeluzole oral suspensions |
| 09/24/1997 | CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular. |
| 09/24/1997 | CN1160345A Improved method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
| 09/24/1997 | CN1160344A Lyophilizate of Lipid complex of water insoluble camptothecins |
| 09/24/1997 | CN1160053A Process for preparation of enantiomerically pure imidazolyl compounds |
| 09/24/1997 | CN1160052A New crystal modification of quinolinecarboxylic acid hydrochloride, process for its preparation and pharmaceutical formulations comprising this modification |
| 09/24/1997 | CN1160051A New substituted oxazolidinones |
| 09/24/1997 | CN1160045A Matrix metalloprotease inhibitors |
| 09/24/1997 | CN1160042A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/24/1997 | CN1160041A Ortho-substd. benzoyl guanidines, their preparing process and use as medicine and diagnostic reagent, and medicine contg. same |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1159917A Heterogeneous contraception preparation based on natural estrogen |
| 09/24/1997 | CN1159916A Medicine for treatment of common cold |
| 09/24/1997 | CN1159915A Neuroprotective agents |
| 09/24/1997 | CN1035946C Process for preparing heterocyclic compounds |
| 09/24/1997 | CN1035945C Process for preparing 5-alkylquinolonecarboxylic acid derivs. |
| 09/24/1997 | CN1035944C Method for preparing 3-aminopiperidine derivs. and related nitrogen-contg. heterocycles |
| 09/24/1997 | CN1035939C Substd. (arylalkylaminobenzyl) aminopropionamide derivs., their preparation method |